Injury to the cells of the gas exchanging surface of the lung is an unusual event considering the continuing barrage of inhaled irritants and blood-borne chemicals coped with daily. The innate efficiency of the mucociliary and macrophagic systems that keep the alveoli clean and of the detoxifying mechanisms that protect the alveolar capillaries from damage is impressive and cellular stability in the gas exchanging units is reflected in the very slow turnover rate, some four to six weeks, of the alveolar epithelium compared to the cells of the airways which have a lifespan of a few days only.1 Normally, there is little cellular loss within the alveoli and small need for replacement but, like the liver, the reparative potential of the alveolar cells is great and under most circumstances injury is followed rapidly by cellular regeneration with restoration of normal function. The maintenance of a stable milieu within the alveoli is dependent upon an effective interplay of macrophages, epithelial-endothelial lining cells and the miscellany of cellular elements that constitutes the pulmonary interstitium. The interdependence of these phagocytic, gas transporting, and supportive cells is manifest in their different susceptibilities to injury and in their complex interactions during repair and regeneration.
The cells that line the air-blood barrier are exquisitely adapted to their functions of gas exchange and of providing an effective barrier against the leakage of plasma constituents into the alveoli. Further, these cells react speedily to repair breaches in the wall. This delicate structural compromise between the opposing needs of a thin gas-exchanging membrane and a tight defensive barrier has not been achieved without cost however. The show obvious fibrosis. Similarly, the rate of collagen synthesis in cultured explants of these lungs may be normal. Such discrepancies are explained in part by the small size of the biopsy and the possibility that much of the increased interstitial mass observed by the morphologist may not be collagen but an oedematous matrix.19 In addition the invariable increase in cellularity, at least in the early phases of repair, emphasises the need to relate collagen mass to measurements of DNA as well as to the dry weight of the lung. In experimental models of pulmonary fibrosis there is without doubt a real increase of collagenl8 and the conflicting data derived from the lungs of patients with severe restrictive disease are explainable only if one assumes that interstitial pulmonary fibrosis involves not only alterations of quantity but also of the quality, form, and location of collagen.20 Such a conclusion is predicated upon the known lability of collagen and on the concept of turnover whereby collagen secretion is usually balanced by collagen resorption.
There is a tendency to regard fibrosis of the lung as a unidirectional process despite a considerable amount of clinical evidence suggesting reversibility.21 22 The healing of wounds and fractures depends on an increased production of collagen much of which is resorbed subsequently. Experimental work in these and other systems indicates that collagen breakdown is largely an extracellular event involving increased activity of collagenase.23 24 In this process too, cell to cell interactions are essential to the control and modulation of structural remodelling. The dominant effector cells in collagenolysis are fibrobasts and epidermal cells and the chief modulating cells are macrophages. [25] [26] [27] Similar data on collagen remodelling in the lung are not available although a recent paper indicates the continuing presence of collagenase in the alveoli of patients with interstitial pulmonary fibrosis. 28 
